These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25875873)

  • 21. Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site.
    Arimondo PB; Bailly C; Boutorine AS; Moreau P; Prudhomme M; Sun JS; Garestier T; Hélène C
    Bioconjug Chem; 2001; 12(4):501-9. PubMed ID: 11459453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison.
    Godbole AA; Ahmed W; Bhat RS; Bradley EK; Ekins S; Nagaraja V
    Biochem Biophys Res Commun; 2014 Apr; 446(4):916-20. PubMed ID: 24642256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I.
    Bansal S; Sinha D; Singh M; Cheng B; Tse-Dinh YC; Tandon V
    J Antimicrob Chemother; 2012 Dec; 67(12):2882-91. PubMed ID: 22945915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I.
    Cheng B; Liu IF; Tse-Dinh YC
    J Antimicrob Chemother; 2007 Apr; 59(4):640-5. PubMed ID: 17317696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I.
    Yang Z; Jiang T; Zhong H; Kang Y
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):319-323. PubMed ID: 29281935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
    Duan F; Li X; Cai S; Xin G; Wang Y; Du D; He S; Huang B; Guo X; Zhao H; Zhang R; Ma L; Liu Y; Du Q; Wei Z; Xing Z; Liang Y; Wu X; Fan C; Ji C; Zeng D; Chen Q; He Y; Liu X; Huang W
    J Med Chem; 2014 May; 57(9):3707-14. PubMed ID: 24588790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topoisomerase I inhibitor evodiamine acts as an antibacterial agent against drug-resistant Klebsiella pneumoniae.
    Wu JY; Chang MC; Chen CS; Lin HC; Tsai HP; Yang CC; Yang CH; Lin CM
    Planta Med; 2013 Jan; 79(1):27-9. PubMed ID: 23161424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor.
    Cheng B; Cao S; Vasquez V; Annamalai T; Tamayo-Castillo G; Clardy J; Tse-Dinh YC
    PLoS One; 2013; 8(4):e60770. PubMed ID: 23593306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
    Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
    J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
    Basarab GS; Manchester JI; Bist S; Boriack-Sjodin PA; Dangel B; Illingworth R; Sherer BA; Sriram S; Uria-Nickelsen M; Eakin AE
    J Med Chem; 2013 Nov; 56(21):8712-35. PubMed ID: 24098982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.
    van Eijk E; Wittekoek B; Kuijper EJ; Smits WK
    J Antimicrob Chemother; 2017 May; 72(5):1275-1284. PubMed ID: 28073967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial DNA topoisomerases and their inhibition by antibiotics.
    Zimmer C; Störl K; Störl J
    J Basic Microbiol; 1990; 30(3):209-24. PubMed ID: 2164580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.
    Surivet JP; Zumbrunn C; Rueedi G; Hubschwerlen C; Bur D; Bruyère T; Locher H; Ritz D; Keck W; Seiler P; Kohl C; Gauvin JC; Mirre A; Kaegi V; Dos Santos M; Gaertner M; Delers J; Enderlin-Paput M; Boehme M
    J Med Chem; 2013 Sep; 56(18):7396-415. PubMed ID: 23968485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new scaffold of topoisomerase I inhibitors: Design, synthesis and biological evaluation.
    Mazza A; Beccalli EM; Contini A; Garcia-Argaez AN; Dalla Via L; Gelmi ML
    Eur J Med Chem; 2016 Nov; 124():326-339. PubMed ID: 27597409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target.
    Ravishankar S; Ambady A; Awasthy D; Mudugal NV; Menasinakai S; Jatheendranath S; Guptha S; Sharma S; Balakrishnan G; Nandishaiah R; Ramachandran V; Eyermann CJ; Reck F; Rudrapatna S; Sambandamurthy VK; Sharma UK
    Tuberculosis (Edinb); 2015 Sep; 95(5):589-98. PubMed ID: 26073894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New alkaloid antibiotics that target the DNA topoisomerase I of Streptococcus pneumoniae.
    García MT; Blázquez MA; Ferrándiz MJ; Sanz MJ; Silva-Martín N; Hermoso JA; de la Campa AG
    J Biol Chem; 2011 Feb; 286(8):6402-13. PubMed ID: 21169356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Lu J; Patel S; Rickert KW; Smith RF; Soisson S; Sherer E; Joyce LA; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takano H; Shibasaki M; Yajima M; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 May; 25(9):1831-5. PubMed ID: 25851938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors.
    Godbole AA; Ahmed W; Bhat RS; Bradley EK; Ekins S; Nagaraja V
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1549-57. PubMed ID: 25534741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulators: valuable targets for novel antibacterial strategies.
    González A; Fillat MF; Lanas Á
    Future Med Chem; 2018 Mar; 10(5):541-560. PubMed ID: 29461098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.